Recursion Pharmaceuticals (RXRX) Accumulated Expenses (2020 - 2026)
Recursion Pharmaceuticals (RXRX) recorded Accumulated Expenses of $56.94 million in Q2 2026, down 11.4% from $64.28 million a year earlier but up 5.0% from the prior quarter.
Recursion Pharmaceuticals (RXRX) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals reported Accumulated Expenses of $70.23 million, down 14.2% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 46.3% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $81.87 million in FY2024 (+75.6%), $46.64 million in FY2023 (+41.7%), $32.9 million in FY2022 (+1.8%) and $32.33 million in FY2021 (+208.4%).
- Quarterly Accumulated Expenses has ranged from $23.12 million in Q1 2022 to $81.87 million in Q4 2024 over the past five years.
- On a year-over-year basis, Accumulated Expenses has declined for three consecutive quarters, with growth averaging 36.1% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 208.4% in Q4 2021, against a decline of 14.2% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $54.21 million (Q1 2026), $70.23 million (Q4 2025) and $53.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.94 Mn |
| Mar 31, 2026 | 54.21 Mn |
| Dec 31, 2025 | 70.23 Mn |
| Sep 30, 2025 | 53.10 Mn |
| Jun 30, 2025 | 64.28 Mn |
| Mar 31, 2025 | 56.80 Mn |
| Dec 31, 2024 | 81.87 Mn |
| Sep 30, 2024 | 40.60 Mn |
| Jun 30, 2024 | 33.40 Mn |
| Mar 31, 2024 | 26.07 Mn |
| Dec 31, 2023 | 46.64 Mn |
| Sep 30, 2023 | 39.81 Mn |
| Jun 30, 2023 | 32.87 Mn |
| Mar 31, 2023 | 25.04 Mn |
| Dec 31, 2022 | 32.90 Mn |
| Sep 30, 2022 | 26.76 Mn |
| Jun 30, 2022 | 24.36 Mn |
| Mar 31, 2022 | 23.12 Mn |
| Dec 31, 2021 | 32.33 Mn |
| Sep 30, 2021 | 25.11 Mn |
Recursion Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RXRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();